Circulating natriuretic peptide measurements have been used extensively over the past 15
years to diagnose and monitor patients with heart failure. We are still learning how complex …

In the present study, we assessed the use of urinary natriuretic peptides [N-terminal proatrial
natriuretic peptide (N-ANP) and N-terminal pro-brain natriuretic peptide (N-BNP) and C-type …

BACKGROUND: Identification of individuals in the community with left ventricular systolic
dysfunction (LVSD) or left ventricular hypertrophy (LVH) may allow earlier initiation of …

Objectives: To determine whether blood natriuretic peptide concentrations are helpful in
identifying or excluding left ventricular systolic dysfunction in stable survivors of acute …

Objectives: We examined whether measurement of the plasma BNP concentrations might be
useful for the early diagnosis of the existence and severity of disease in patients with heart …

The discovery of cardiac natriuretic peptides two decades ago has lead to considerable
research to investigate their biochemical and physiological properties. Clearly the heart is …

Background The reliability of a clinical diagnosis of heart failure in primary care is poor.
Concentrations of natriuretic peptides are high in heart failure. This population-based study …

Objectives: Midregional pro-atrial natriuretic peptide (MR-proANP) was assessed for the
importance of influencing factors, the ability to detect left ventricular systolic dysfunction, and …

The present study was designed to investigate whether brain natriuretic peptide (BNP) and
atrial natriuretic peptide (ANP) plasma concentrations correlate with left ventricular end …

PURPOSE: Although echocardiography is important for making the diagnosis of left
ventricular dysfunction, its cost and lack of availability limit its use as a routine screening test …